|
|
DSpace at RU >
Browsing by Author Rasch, C.R.
Showing results 1 to 14 of 14
| Full Text | Issue Date | Title | Author(s) | | 2011 | Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer | Knegjens, J.L.; Hauptmann, M.; Pameijer, F.A.; Balm, A.J.M.; Hoebers, F.J., et al |
| 2011 | Semi-automatic delineation using weighted CT-MRI registered images for radiotherapy of nasopharyngeal cancer | Fitton, I.; Cornelissen, S.; Duppen, J.C.; Steenbakkers, R.J.; Peeters, S.T., et al |
| 2010 | Decreased 3D observer variation with matched CT-MRI, for target delineation in nasopharynx cancer | Rasch, C.R.; Steenbakkers, R.J.; Fitton, I.; Duppen, J.C.; Nowak, P.J., et al |
| 2010 | HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors. | Jong, M.C.J. de; Pramana, J.; Knegjens, J.L.; Balm, A.J.; Brekel, M.W. van den, et al |
| 2010 | CD44 expression predicts local recurrence after radiotherapy in larynx cancer. | Jong, M.C.J. de; Pramana, J.; Wal, J.E. van der; Lacko, M.; Peutz-Kootstra, C.J., et al |
| 2009 | Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation. | Broek, G.B. van den; Wildeman, M.; Rasch, C.R.; Armstrong, N.; Schuuring, E., et al |
| 2009 | De Condor Studie: een gerandomiseerde fase-II studie met chemotherapie met Docetaxel/cisplatine/5-fluorouracil gevolgd door concomitante chemo-radiotherapie met conventionele radiotherapie of met geaccelereerde radiotherapie bij patiƫnten met lokaal uitgebreide hoofd-halskanker, die in goede conditie zijn. Een studie van de Nederlandse Werkgroep Hoofd-Hals-Tumoren (NWHHT 08-01) | Herpen, C.M.L. van; Boer, J.P. de; Rasch, C.R.; Kaanders, J.H.A.M. |
| 2008 | Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor. | Hoebers, F.J.; Pluim, D.; Hart, A.A.M.; Verheij, M.; Balm, A.J.M., et al |
| 2007 | Gene expression profiling to predict outcome after chemoradiation in head and neck cancer. | Pramana, J.; Brekel, M.W. van den; Velthuysen, M.L. van; Wessels, L.F.; Nuyten, D.S., et al |
| 2007 | Heterogeneity of gene expression profiles in head and neck cancer. | Pramana, J.; Pimentel, N.; Hofland, I.; Wessels, L.F.; Velthuysen, M.L. van, et al |
| 2006 | Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. | Steenbakkers, R.J.; Duppen, J.C.; Fitton, I.; Deurloo, K.E.; Zijp, L.J., et al |
| 2005 | Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation. | Steenbakkers, R.J.; Duppen, J.C.; Fitton, I.; Deurloo, K.E.; Zijp, L., et al |
| 2005 | The role of radiotherapy in the treatment of malignant salivary gland tumors. | Terhaard, C.H.J.; Lubsen, H.; Rasch, C.R.; Levendag, P.C.; Kaanders, J.H.A.M., et al |
| 2004 | High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. | Balm, A.J.M.; Rasch, C.R.; Schornagel, J.H.; Hilgers, F.J.M.; Keus, R.B., et al |
Showing results 1 to 14 of 14
|